Skip to main content

Articles

Page 43 of 48

  1. A wide variety of high-throughput microarray platforms have been used to identify molecular targets associated with biological and clinical tumor phenotypes by comparing samples representing distinct pathologi...

    Authors: Waleska K Martins, Gustavo H Esteves, Otávio M Almeida, Gisele G Rezze, Gilles Landman, Sarah M Marques, Alex F Carvalho, Luiz F L Reis, João P Duprat and Beatriz S Stolf
    Citation: BMC Medical Genomics 2011 4:76
  2. Gene fusions arising from chromosomal translocations have been implicated in cancer. However, the role of gene fusions in BRCA1-related breast cancers is not well understood. Mutations in BRCA1 are associated wit...

    Authors: Kevin CH Ha, Emilie Lalonde, Lili Li, Luca Cavallone, Rachael Natrajan, Maryou B Lambros, Costas Mitsopoulos, Jarle Hakas, Iwanka Kozarewa, Kerry Fenwick, Chris J Lord, Alan Ashworth, Anne Vincent-Salomon, Mark Basik, Jorge S Reis-Filho, Jacek Majewski…
    Citation: BMC Medical Genomics 2011 4:75
  3. Sporadic amyotrophic lateral sclerosis (sALS) is a motor neuron disease with poorly understood etiology. Results of gene expression profiling studies of whole blood from ALS patients have not been validated an...

    Authors: Jean-Luc C Mougeot, Zhen Li, Andrea E Price, Fred A Wright and Benjamin R Brooks
    Citation: BMC Medical Genomics 2011 4:74
  4. Insulin resistance (IR) is accompanied by chronic low grade systemic inflammation, obesity, and deregulation of total body energy homeostasis. We induced inflammation in adipose and liver tissues in vitro in orde...

    Authors: Ewa Szalowska, Martijn Dijkstra, Marieke GL Elferink, Desiree Weening, Marcel de Vries, Marcel Bruinenberg, Annemieke Hoek, Han Roelofsen, Geny MM Groothuis and Roel J Vonk
    Citation: BMC Medical Genomics 2011 4:71
  5. The accurate diagnosis of idiopathic pulmonary fibrosis (IPF) is a major clinical challenge. We developed a model to diagnose IPF by applying Bayesian probit regression (BPR) modelling to gene expression profi...

    Authors: Eric B Meltzer, William T Barry, Thomas A D'Amico, Robert D Davis, Shu S Lin, Mark W Onaitis, Lake D Morrison, Thomas A Sporn, Mark P Steele and Paul W Noble
    Citation: BMC Medical Genomics 2011 4:70
  6. The ability to share human biological samples, associated data and results across disease-specific and population-based human research biobanks is becoming increasingly important for research into disease deve...

    Authors: Isabelle Budin-Ljøsne, Anne Marie Tassé, Bartha Maria Knoppers and Jennifer R Harris
    Citation: BMC Medical Genomics 2011 4:69
  7. Massively parallel sequencing technologies have brought an enormous increase in sequencing throughput. However, these technologies need to be further improved with regard to reproducibility and applicability t...

    Authors: Martin Kerick, Melanie Isau, Bernd Timmermann, Holger Sültmann, Ralf Herwig, Sylvia Krobitsch, Georg Schaefer, Irmgard Verdorfer, Georg Bartsch, Helmut Klocker, Hans Lehrach and Michal R Schweiger
    Citation: BMC Medical Genomics 2011 4:68
  8. Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35. Within each repeat unit is a gene, DUX4, that can encode a protein co...

    Authors: Koji Tsumagari, Shao-Chi Chang, Michelle Lacey, Carl Baribault, Sridar V Chittur, Janet Sowden, Rabi Tawil, Gregory E Crawford and Melanie Ehrlich
    Citation: BMC Medical Genomics 2011 4:67
  9. Conventional high-grade osteosarcoma is a primary malignant bone tumor, which is most prevalent in adolescence. Survival rates of osteosarcoma patients have not improved significantly in the last 25 years. Aim...

    Authors: Marieke L Kuijjer, Heidi M Namløs, Esther I Hauben, Isidro Machado, Stine H Kresse, Massimo Serra, Antonio Llombart-Bosch, Pancras CW Hogendoorn, Leonardo A Meza-Zepeda, Ola Myklebost and Anne-Marie Cleton-Jansen
    Citation: BMC Medical Genomics 2011 4:66
  10. Mesenchymal stem cell (MSC) found in bone marrow (BM-MSCs) and the Wharton's jelly matrix of human umbilical cord (WJ-MSCs) are able to transdifferentiate into neuronal lineage cells both in vitro and in vivo and...

    Authors: Shing-Jyh Chang, Shun-Long Weng, Jui-Yu Hsieh, Tao-Yeuan Wang, Margaret Dah-Tsyr Chang and Hsei-Wei Wang
    Citation: BMC Medical Genomics 2011 4:65
  11. It is widely accepted that atherosclerosis and inflammation are intimately linked. Monocytes play a key role in both of these processes and we hypothesized that activation of inflammatory pathways in monocytes...

    Authors: Suthesh Sivapalaratnam, Rosienne Farrugia, Max Nieuwdorp, Cordelia F Langford, Rachel T van Beem, Stephanie Maiwald, Jaap Jan Zwaginga, Arief Gusnanto, Nicholas A Watkins, Mieke D Trip and Willem H Ouwehand
    Citation: BMC Medical Genomics 2011 4:64
  12. Glioblastoma multiforme (GBM) tends to occur between the ages of 45 and 70. This relatively early onset and its poor prognosis make the impact of GBM on public health far greater than would be suggested by its...

    Authors: Tun-Hsiang Yang, Mark Kon, Jui-Hung Hung and Charles DeLisi
    Citation: BMC Medical Genomics 2011 4:63
  13. Incidence of hepatitis C virus (HCV) induced hepatocellular carcinoma (HCC) has been increasing in the United States and Europe during recent years. Although HCV-associated HCC shares many pathological charact...

    Authors: Siyuan Zheng, William P Tansey, Scott W Hiebert and Zhongming Zhao
    Citation: BMC Medical Genomics 2011 4:62
  14. Transgenic mouse tumor models have the advantage of facilitating controlled in vivo oncogenic perturbations in a common genetic background. This provides an idealized context for generating transcriptome-based di...

    Authors: Heather G LaBreche, Joseph R Nevins and Erich Huang
    Citation: BMC Medical Genomics 2011 4:61
  15. Hepatocellular carcinoma (HCC) is a worldwide malignant liver tumor with high incidence in China. Subchromosomal amplifications and deletions accounted for major genomic alterations occurred in HCC. Digital ka...

    Authors: Hui Dong, Hongyi Zhang, Jianping Liang, Huadong Yan, Yangyi Chen, Yan Shen, Yalin Kong, Shengyue Wang, Guoping Zhao and Weirong Jin
    Citation: BMC Medical Genomics 2011 4:60
  16. Inflammation plays an important role in cardiac repair after myocardial infarction (MI). Nevertheless, the systems-level characterization of inflammation proteins in MI remains incomplete. There is a need to d...

    Authors: Francisco J Azuaje, Sophie Rodius, Lu Zhang, Yvan Devaux and Daniel R Wagner
    Citation: BMC Medical Genomics 2011 4:59
  17. Gene expression signatures developed to measure the activity of oncogenic signaling pathways have been used to dissect the heterogeneity of tumor samples and to predict sensitivity to various cancer drugs that...

    Authors: Jennifer A Freedman, Christina K Augustine, Angelica M Selim, Kirsten C Holshausen, Zhengzheng Wei, Katherine A Tsamis, David S Hsu, Holly K Dressman, William T Barry, Douglas S Tyler and Joseph R Nevins
    Citation: BMC Medical Genomics 2011 4:58
  18. Pilocytic Astrocytomas (PAs) are common low-grade central nervous system malignancies for which few recurrent and specific genetic alterations have been identified. In an effort to better understand the molecu...

    Authors: Hrishikesh Deshmukh, Jinsheng Yu, Jahangheer Shaik, Tobey J MacDonald, Arie Perry, Jacqueline E Payton, David H Gutmann, Mark A Watson and Rakesh Nagarajan
    Citation: BMC Medical Genomics 2011 4:57
  19. Metastasis is the number one cause of cancer deaths. Expression microarrays have been widely used to study metastasis in various types of cancer. We hypothesize that a meta-analysis of publicly available gene ...

    Authors: Marla H Daves, Susan G Hilsenbeck, Ching C Lau and Tsz-Kwong Man
    Citation: BMC Medical Genomics 2011 4:56
  20. A molecular characterization of Alzheimer's Disease (AD) is the key to the identification of altered gene sets that lead to AD progression. We rely on the assumption that candidate marker genes for a given dis...

    Authors: Margherita Squillario and Annalisa Barla
    Citation: BMC Medical Genomics 2011 4:55
  21. Genomic tests are available to predict breast cancer recurrence and to guide clinical decision making. These predictors provide recurrence risk scores along with a measure of uncertainty, usually a confidence ...

    Authors: Fathi Elloumi, Zhiyuan Hu, Yan Li, Joel S Parker, Margaret L Gulley, Keith D Amos and Melissa A Troester
    Citation: BMC Medical Genomics 2011 4:54
  22. Cancer cells are characterized by massive dysegulation of physiological cell functions with considerable disruption of transcriptional regulation. Genome-wide transcriptome profiling can be utilized for early ...

    Authors: Markus Krupp, Thorsten Maass, Jens U Marquardt, Frank Staib, Tobias Bauer, Rainer König, Stefan Biesterfeld, Peter R Galle, Achim Tresch and Andreas Teufel
    Citation: BMC Medical Genomics 2011 4:53
  23. Recent genome-wide association (GWA) analyses have identified common single nucleotide polymorphisms (SNPs) that are associated with obesity. However, the reported genetic variation in obesity explains only a ...

    Authors: Hong Jiao, Peter Arner, Johan Hoffstedt, David Brodin, Beatrice Dubern, Sébastien Czernichow, Ferdinand van't Hooft, Tomas Axelsson, Oluf Pedersen, Torben Hansen, Thorkild IA Sørensen, Johannes Hebebrand, Juha Kere, Karin Dahlman-Wright, Anders Hamsten, Karine Clement…
    Citation: BMC Medical Genomics 2011 4:51
  24. We performed a genome-wide scan of 27,578 CpG loci covering 14,475 genes to identify differentially methylated loci (DML) in colorectal carcinoma (CRC).

    Authors: Muhammad G Kibriya, Maruf Raza, Farzana Jasmine, Shantanu Roy, Rachelle Paul-Brutus, Ronald Rahaman, Charlotte Dodsworth, Muhammad Rakibuz-Zaman, Mohammed Kamal and Habibul Ahsan
    Citation: BMC Medical Genomics 2011 4:50
  25. Glioblastoma is a complex multifactorial disorder that has swift and devastating consequences. Few genes have been consistently identified as prognostic biomarkers of glioblastoma survival. The goal of this st...

    Authors: Nicola VL Serão, Kristin R Delfino, Bruce R Southey, Jonathan E Beever and Sandra L Rodriguez-Zas
    Citation: BMC Medical Genomics 2011 4:49
  26. Gastric cancer samples obtained by histologic macrodissection contain a relatively high stromal content that may significantly influence gene expression profiles. Differences between the gene expression signat...

    Authors: Hark Kyun Kim, Joseph Kim, Susie Korolevich, Il Ju Choi, Chang Hee Kim, David J Munroe and Jeffrey E Green
    Citation: BMC Medical Genomics 2011 4:48
  27. Copy number variants (CNV) are a potentially important component of the genetic contribution to risk of common complex diseases. Analysis of the association between CNVs and disease requires that uncertainty i...

    Authors: Isaac Subirana, Ramon Diaz-Uriarte, Gavin Lucas and Juan R Gonzalez
    Citation: BMC Medical Genomics 2011 4:47
  28. Prostate tumor heterogeneity is a major factor in disease management. Heterogeneity could be due to multiple cancer cell types with distinct gene expression. Of clinical importance is the so-called cancer stem...

    Authors: Laura E Pascal, Ricardo ZN Vêncio, Robert L Vessella, Carol B Ware, Eneida F Vêncio, Gareth Denyer and Alvin Y Liu
    Citation: BMC Medical Genomics 2011 4:46
  29. Bladder cancer is the sixth most common cancer in the world and the incidence is particularly high in southwestern Taiwan. Previous studies have identified several tumor-related genes that are hypermethylated ...

    Authors: Pi-Che Chen, Ming-Hsuan Tsai, Sidney KH Yip, Yeong-Chin Jou, Chi-Fai Ng, Yanning Chen, Xiaoling Wang, Wei Huang, Chun-Liang Tung, Gary CW Chen, Martin MS Huang, Joanna HM Tong, Eing-Ju Song, De-Ching Chang, Cheng-Da Hsu, Ka-Fai To…
    Citation: BMC Medical Genomics 2011 4:45
  30. Cancer is a disease of genome alterations that arise through the acquisition of multiple somatic DNA sequence mutations. Some of these mutations can be critical for the development of a tumor and can be useful...

    Authors: Jan Küntzer, Daniela Maisel, Hans-Peter Lenhof, Stefan Klostermann and Helmut Burtscher
    Citation: BMC Medical Genomics 2011 4:43
  31. Recent studies have identified thousands of sense-antisense gene pairs across different genomes by computational mapping of cDNA sequences. These studies have shown that approximately 25% of all transcriptiona...

    Authors: Rintaro Saito, Keisuke Kohno, Yuki Okada, Yuko Osada, Koji Numata, Chihiro Kohama, Kazufumi Watanabe, Hajime Nakaoka, Naoyuki Yamamoto, Akio Kanai, Hiroshi Yasue, Soichiro Murata, Kuniya Abe, Masaru Tomita, Nobuhiro Ohkohchi and Hidenori Kiyosawa
    Citation: BMC Medical Genomics 2011 4:42
  32. The zebrafish is recognized as a versatile cancer and drug screening model. However, it is not known whether the estrogen-responsive genes and signaling pathways that are involved in estrogen-dependent carcino...

    Authors: Siew Hong Lam, Serene GP Lee, Chin Y Lin, Jane S Thomsen, Pan Y Fu, Karuturi RK Murthy, Haixia Li, Kunde R Govindarajan, Lin CH Nick, Guillaume Bourque, Zhiyuan Gong, Thomas Lufkin, Edison T Liu and Sinnakaruppan Mathavan
    Citation: BMC Medical Genomics 2011 4:41
  33. Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. Approximately 95% of patients with Type 1 diabetes develop some degree of retinopathy within 25 years of diagnosis despite norma...

    Authors: Georgina V Bixler, Heather D VanGuilder, Robert M Brucklacher, Scot R Kimball, Sarah K Bronson and Willard M Freeman
    Citation: BMC Medical Genomics 2011 4:40
  34. The gene CHEK2 encodes a checkpoint kinase playing a key role in the DNA damage pathway. Though CHEK2 has been identified as an intermediate breast cancer susceptibility gene, only a small proportion of high-risk...

    Authors: Tú Nguyen-Dumont, Lars P Jordheim, Jocelyne Michelon, Nathalie Forey, Sandrine McKay-Chopin, Olga Sinilnikova, Florence Le Calvez-Kelm, Melissa C Southey, Sean V Tavtigian and Fabienne Lesueur
    Citation: BMC Medical Genomics 2011 4:39
  35. Traditional Chinese Medicine (TCM) has been used for thousands of years to treat or prevent diseases, including cancer. Good manufacturing practices (GMP) and sophisticated product analysis (PhytomicsQC) to en...

    Authors: Ena Wang, Scott Bussom, Jinguo Chen, Courtney Quinn, Davide Bedognetti, Wing Lam, Fulan Guan, Zaoli Jiang, Yichao Mark, Yingdong Zhao, David F Stroncek, Jeffrey White, Francesco M Marincola and Yung-Chi Cheng
    Citation: BMC Medical Genomics 2011 4:38
  36. Recent observations point towards the existence of a large number of neighborhoods composed of functionally-related gene modules that lie together in the genome. This local component in the distribution of the...

    Authors: Eva Alloza, Fátima Al-Shahrour, Juan C Cigudosa and Joaquín Dopazo
    Citation: BMC Medical Genomics 2011 4:37
  37. Myostatin is a potent muscle growth inhibitor that belongs to the Transforming Growth Factor-β (TGF-β) family. Mutations leading to non functional myostatin have been associated with hypermuscularity in severa...

    Authors: Dwi U Kemaladewi, Willem MH Hoogaars, Sandra H van Heiningen, Samuel Terlouw, David JJ de Gorter, Johan T den Dunnen, Gert Jan B van Ommen, Annemieke Aartsma-Rus, Peter ten Dijke and Peter AC 't Hoen
    Citation: BMC Medical Genomics 2011 4:36
  38. Neuroblastoma (NB) tumors are well known for their pronounced clinical and molecular heterogeneity. The global gene expression and DNA copy number alterations have been shown to have profound differences in tu...

    Authors: Xiang Guo, Qing-Rong Chen, Young K Song, Jun S Wei and Javed Khan
    Citation: BMC Medical Genomics 2011 4:35
  39. Assays of multiple tumor samples frequently reveal recurrent genomic aberrations, including point mutations and copy-number alterations, that affect individual genes. Analyses that extend beyond single genes a...

    Authors: Christopher A Miller, Stephen H Settle, Erik P Sulman, Kenneth D Aldape and Aleksandar Milosavljevic
    Citation: BMC Medical Genomics 2011 4:34
  40. Cancer shows a great diversity in its clinical behavior which cannot be easily predicted using the currently available clinical or pathological markers. The identification of pathways associated with lymph nod...

    Authors: Anna EL Coló, Ana CQ Simoes, André L Carvalho, Camila M Melo, Lucas Fahham, Luiz P Kowalski, Fernando A Soares, Eduardo J Neves, Luiz FL Reis and Alex F Carvalho
    Citation: BMC Medical Genomics 2011 4:33
  41. Comparative Genomic Hybridization (CGH) is a molecular approach for detecting DNA Copy Number Alterations (CNAs) in tumor, which are among the key causes of tumorigenesis. However in the post-genomic era, most...

    Authors: Huimin Geng, Javeed Iqbal, Wing C Chan and Hesham H Ali
    Citation: BMC Medical Genomics 2011 4:32
  42. Several DNA microarray based expression signatures for the different clinically relevant thyroid tumor entities have been described over the past few years. However, reproducibility of these signatures is gene...

    Authors: Klemens Vierlinger, Markus H Mansfeld, Oskar Koperek, Christa Nöhammer, Klaus Kaserer and Friedrich Leisch
    Citation: BMC Medical Genomics 2011 4:30
  43. Postmenopausal hormone therapy (HT) influences endogenous hormone concentrations and increases the risk of breast cancer. Gene expression profiling may reveal the mechanisms behind this relationship.

    Authors: Marit Waaseth, Karina S Olsen, Charlotta Rylander, Eiliv Lund and Vanessa Dumeaux
    Citation: BMC Medical Genomics 2011 4:29
  44. The immune contribution to cancer progression is complex and difficult to characterize. For example in tumors, immune gene expression is detected from the combination of normal, tumor and immune cells in the t...

    Authors: Trevor Clancy, Marco Pedicini, Filippo Castiglione, Daniele Santoni, Vegard Nygaard, Timothy J Lavelle, Mikael Benson and Eivind Hovig
    Citation: BMC Medical Genomics 2011 4:28
  45. Diagnostic accuracy of lymphoma, a heterogeneous cancer, is essential for patient management. Several ancillary tests including immunophenotyping, and sometimes cytogenetics and PCR are required to aid histolo...

    Authors: To Ha Loi, Anna Campain, Adam Bryant, Tim J Molloy, Mark Lutherborrow, Jennifer Turner, Yee Hwa Jean Yang and David DF Ma
    Citation: BMC Medical Genomics 2011 4:27

Annual Journal Metrics

  • 2022 Citation Impact
    2.7 - 2-year Impact Factor
    3.2 - 5-year Impact Factor
    0.730 - SNIP (Source Normalized Impact per Paper)
    0.892 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    164 days submission to accept (Median)

    2023 Usage 
    1,335,753 downloads
    593 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal